http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#Head
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#assertion
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#provenance
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#pubinfo
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#assertion
http://purl.obolibrary.org/obo/DOID_0050782
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_0050782
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00736
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#association
http://www.w3.org/2000/01/rdf-schema#label
esomeprazole magnesium delayed release capsules usp are a proton pump inhibitor indicated for the following treatment of gastroesophageal reflux disease gerd 1 1 risk reduction of nsaid associated gastric ulcer 1 2 eradication to reduce the risk of duodenal ulcer recurrence h pylori 1 3 pathological hypersecretory conditions including zollinger ellison syndrome 1 4 healing of erosive esophagitis esomeprazole magnesium delayed release capsules usp are indicated for the short term treatment 4 to 8 weeks in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis for those patients who have not healed after 4 to 8 weeks of treatment an additional 4 to 8 week course of esomeprazole magnesium delayed release capsules usp may be considered maintenance of healing of erosive esophagitis esomeprazole magnesium delayed release capsules usp are indicated to maintain symptom resolution and healing of erosive esophagitis controlled studies do not extend beyond 6 months symptomatic gastroesophageal reflux disease esomeprazole magnesium delayed release capsules usp are indicated for short term treatment 4 to 8 weeks of heartburn and other symptoms associated with gerd in adults and children 1 year or older esomeprazole magnesium delayed release capsules usp are indicated for the reduction in the occurrence of gastric ulcers associated with continuous nsaid therapy in patients at risk for developing gastric ulcers patients are considered to be at risk due to their age 6 and or documented history of gastric ulcers controlled studies do not extend beyond 6 months triple therapy esomeprazole magnesium delayed release capsules usp plus amoxicillin and clarithromycin esomeprazole magnesium delayed release capsules usp in combination with amoxicillin and clarithromycin is indicated for the treatment of patients with infection and duodenal ulcer disease active or history of within the past 5 years to eradicate eradication of has been shown to reduce the risk of duodenal ulcer recurrence h pylori h pylori h pylori see dosage and administration and clinical studies 2 14 in patients who fail therapy susceptibility testing should be done if resistance to clarithromycin is demonstrated or susceptibility testing is not possible alternative antimicrobial therapy should be instituted see clinical pharmacology and the prescribing information for clarithromycin 12 4 esomeprazole magnesium delayed release capsules usp are indicated for the long term treatment of pathological hypersecretory conditions including zollinger ellison syndrome
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00736
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#provenance
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#pubinfo
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#sig
http://purl.org/nanopub/x/hasSignature
dRauIFXjnJiwt7vy3OzEPBnlJeAlAr2eQOJNS33TcnJ+EKXuWnQBp8KraPopCzA59/x9idN5QI4VLVohlvujEvDLVg2KF+Ml6OAGGNXFvhzqnhFuWDx47mDjCzCxlsVeP2qFG84EIC46axNqMu56vYeyZEatfcs4lo3VZ3EjxMs=
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY
http://purl.org/dc/terms/created
2021-06-27T20:37:47.739+02:00
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAJRlYh0MEUwQvucaJKhNIIeL9hxyQ5KocO-pag4f8LiY
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs